These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37759493)

  • 1. Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19.
    Zingaropoli MA; Pasculli P; Barbato C; Petrella C; Fiore M; Dominelli F; Latronico T; Ciccone F; Antonacci M; Liuzzi GM; Talarico G; Bruno G; Galardo G; Pugliese F; Lichtner M; Mastroianni CM; Minni A; Ciardi MR
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759493
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
    Kanberg N; Simrén J; Edén A; Andersson LM; Nilsson S; Ashton NJ; Sundvall PD; Nellgård B; Blennow K; Zetterberg H; Gisslén M
    EBioMedicine; 2021 Aug; 70():103512. PubMed ID: 34333238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
    Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
    Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
    Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.
    Baiardi S; Quadalti C; Mammana A; Dellavalle S; Zenesini C; Sambati L; Pantieri R; Polischi B; Romano L; Suffritti M; Bentivenga GM; Randi V; Stanzani-Maserati M; Capellari S; Parchi P
    Alzheimers Res Ther; 2022 Oct; 14(1):153. PubMed ID: 36221099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19.
    Bark L; Larsson IM; Wallin E; Simrén J; Zetterberg H; Lipcsey M; Frithiof R; Rostami E; Hultström M
    Sci Rep; 2023 Aug; 13(1):13144. PubMed ID: 37573366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
    Kanberg N; Ashton NJ; Andersson LM; Yilmaz A; Lindh M; Nilsson S; Price RW; Blennow K; Zetterberg H; Gisslén M
    Neurology; 2020 Sep; 95(12):e1754-e1759. PubMed ID: 32546655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-Axonal Damage and Alteration of Blood-Brain Barrier Integrity in COVID-19 Patients.
    Zingaropoli MA; Iannetta M; Piermatteo L; Pasculli P; Latronico T; Mazzuti L; Campogiani L; Duca L; Ferraguti G; De Michele M; Galardo G; Pugliese F; Antonelli G; Andreoni M; Sarmati L; Lichtner M; Turriziani O; Ceccherini-Silberstein F; Liuzzi GM; Mastroianni CM; Ciardi MR
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood Biomarkers as Prognostic Indicators for Neurological Injury in COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Huang Z; Haile K; Gedefaw L; Lau BW; Jin L; Yip SP; Huang CL
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting.
    Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N
    Sci Rep; 2023 Mar; 13(1):5217. PubMed ID: 36997567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study.
    Calcagno A; Cusato J; Cinque P; Marchetti G; Bernasconi D; Trunfio M; Bruzzesi E; Rusconi S; Gabrieli A; Muscatello A; Antinori A; Ripamonti D; Gulminetti R; Antonucci M; Nozza S
    Brain; 2024 Nov; 147(11):3742-3750. PubMed ID: 39171829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury.
    Andersson E; Öst M; Dalla K; Zetterberg H; Blennow K; Nellgård B
    Neurocrit Care; 2024 Dec; 41(3):813-827. PubMed ID: 38769253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction.
    Vågberg M; Norgren N; Dring A; Lindqvist T; Birgander R; Zetterberg H; Svenningsson A
    PLoS One; 2015; 10(8):e0135886. PubMed ID: 26317831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.
    Grahn A; Hagberg L; Nilsson S; Blennow K; Zetterberg H; Studahl M
    J Neurol; 2013 Jul; 260(7):1813-21. PubMed ID: 23471614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms.
    Sahin BE; Celikbilek A; Kocak Y; Saltoglu GT; Konar NM; Hizmali L
    J Neurol Sci; 2022 Aug; 439():120324. PubMed ID: 35752131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection.
    Peluso MJ; Sans HM; Forman CA; Nylander AN; Ho HE; Lu S; Goldberg SA; Hoh R; Tai V; Munter SE; Chenna A; Yee BC; Winslow JW; Petropoulos CJ; Martin JN; Kelly JD; Durstenfeld MS; Hsue PY; Hunt PW; Greene M; Chow FC; Hellmuth J; Henrich TJ; Glidden DV; Deeks SG
    Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35701186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy.
    van Ballegoij WJC; van de Stadt SIW; Huffnagel IC; Kemp S; Willemse EAJ; Teunissen CE; Engelen M
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2127-2136. PubMed ID: 33047897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.